IN2014DN07326A - - Google Patents

Info

Publication number
IN2014DN07326A
IN2014DN07326A IN7326DEN2014A IN2014DN07326A IN 2014DN07326 A IN2014DN07326 A IN 2014DN07326A IN 7326DEN2014 A IN7326DEN2014 A IN 7326DEN2014A IN 2014DN07326 A IN2014DN07326 A IN 2014DN07326A
Authority
IN
India
Prior art keywords
total
citrate
present
invention concerns
magnesium
Prior art date
Application number
Other languages
English (en)
Inventor
Anders Nilsson
Jan Sternby
Anders Wieslander
Original Assignee
Gambro Lundia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gambro Lundia Ab filed Critical Gambro Lundia Ab
Publication of IN2014DN07326A publication Critical patent/IN2014DN07326A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1654—Dialysates therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/32—Manganese; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Diabetes (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • External Artificial Organs (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IN7326DEN2014 2012-03-08 2013-03-05 IN2014DN07326A (enExample)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE1250217A SE536913C2 (sv) 2012-03-08 2012-03-08 Komposition för dialys
US201261608660P 2012-03-09 2012-03-09
PCT/EP2013/054386 WO2013131906A1 (en) 2012-03-08 2013-03-05 Dialysis composition comprising citrate, calcium and magnesium

Publications (1)

Publication Number Publication Date
IN2014DN07326A true IN2014DN07326A (enExample) 2015-04-24

Family

ID=49115964

Family Applications (1)

Application Number Title Priority Date Filing Date
IN7326DEN2014 IN2014DN07326A (enExample) 2012-03-08 2013-03-05

Country Status (10)

Country Link
US (2) US9452149B2 (enExample)
EP (2) EP4223290B1 (enExample)
JP (1) JP6125545B2 (enExample)
KR (1) KR102062932B1 (enExample)
CN (1) CN104159579B (enExample)
AU (1) AU2013201615B2 (enExample)
CA (1) CA2865315C (enExample)
IN (1) IN2014DN07326A (enExample)
SE (1) SE536913C2 (enExample)
WO (1) WO2013131906A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6049685B2 (ja) 2011-03-23 2016-12-21 ネクステージ メディカル インコーポレイテッド 腹膜透析使い捨てユニット、コントローラ、腹膜透析システム
US9861733B2 (en) 2012-03-23 2018-01-09 Nxstage Medical Inc. Peritoneal dialysis systems, devices, and methods
SE536913C2 (sv) * 2012-03-08 2014-10-28 Gambro Lundia Ab Komposition för dialys
PL3489254T3 (pl) 2012-04-30 2023-01-30 Biocon Limited Ukierunkowujące/immunomodulujące białko fuzyjne i sposoby jego otrzymywania
MY186864A (en) 2013-03-12 2021-08-26 Biocon Ltd Fusion immunomodulatory proteins and methods for making same
PT2826476T (pt) * 2013-07-16 2021-03-25 Jan Van Der Meulen Fluido de diálise isento de cálcio
WO2018237375A1 (en) 2017-06-24 2018-12-27 Nxstage Medical, Inc. Peritoneal dialysis fluid preparation and/or treatment devices methods and systems
CA3092575A1 (en) 2018-02-28 2019-09-06 Nxstage Medical, Inc. Fluid preparation and treatment devices, methods, and systems

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3560380A (en) 1968-10-28 1971-02-02 Mallinckrodt Chemical Works Dry concentrates for preparing hemodialysis solutions
US4756838A (en) 1980-02-21 1988-07-12 Veltman Preston Leonard Preparation of dry dialysate products
CA1241886A (en) 1983-04-13 1988-09-13 Peter W. Field Enema bag
US4616671A (en) 1984-01-27 1986-10-14 Trw Inc. Valve with flow force compensator
DE3707190A1 (de) 1987-03-06 1988-09-22 Pav Praezisions Apparatebau Ag Messkluppe
JP2749375B2 (ja) 1989-05-26 1998-05-13 テルモ 株式会社 血液透析用製剤およびその製造方法
AU627309B2 (en) 1989-05-26 1992-08-20 Terumo Kabushiki Kaisha Preparation for blood dialysis and method for production thereof
US5071558A (en) 1989-08-11 1991-12-10 Nikkiso Co., Ltd. Sodium bicarbonate dialysate
WO1992011046A1 (en) 1990-12-18 1992-07-09 The Board Of Regents Of The University Of Washington Dialysate production system with dialysate pellets
JPH04257522A (ja) 1991-02-07 1992-09-11 Nikkiso Co Ltd 重曹透析用剤
JP2769592B2 (ja) 1992-12-14 1998-06-25 富田製薬株式会社 重炭酸透析用人工腎臓灌流用剤の製造方法及び人工腎臓灌流用剤
JP3619921B2 (ja) 1996-09-13 2005-02-16 富田製薬株式会社 重炭酸固形透析用剤
FR2766797B1 (fr) 1997-07-30 1999-09-17 Smad Conditionnement pour au moins une matiere solide, notamment sous forme granuleuse ou pulverulente
US7670491B2 (en) 1998-10-20 2010-03-02 Advanced Renal Technologies Buffered compositions for dialysis
US6610206B1 (en) 1998-10-20 2003-08-26 Advanced Renal Technologies Buffered compositions for dialysis
US6274103B1 (en) 1999-03-26 2001-08-14 Prismedical Corporation Apparatus and method for preparation of a peritoneal dialysis solution
SE9901165D0 (sv) 1999-03-30 1999-03-30 Gambro Lundia Ab Method, apparatus and components of dialysis systems
EP1059083B1 (en) 1999-06-07 2004-04-14 Nipro Corporation A solid pharmaceutical preparation for dialysis and a process for producing the same
WO2001021233A1 (en) * 1999-09-22 2001-03-29 Advanced Renal Technologies High citrate dialysate and uses thereof
DE19955578C1 (de) 1999-11-18 2001-09-06 Fresenius Medical Care De Gmbh Mehrkammerbehälter, mit Glucosekonzentratkompartiment und Salzsäurekonzentratkompartiment
JP3899506B2 (ja) 2000-09-27 2007-03-28 ニプロ株式会社 固形透析用製剤およびその製造方法
JP5204359B2 (ja) 2001-09-28 2013-06-05 味の素株式会社 透析用剤およびその製造方法
SE525132C2 (sv) 2001-11-23 2004-12-07 Gambro Lundia Ab Metod vid manövrering av dialysanordning
US7238164B2 (en) 2002-07-19 2007-07-03 Baxter International Inc. Systems, methods and apparatuses for pumping cassette-based therapies
JP4328851B2 (ja) 2003-03-03 2009-09-09 富田製薬株式会社 重炭酸固形透析剤
JP4647953B2 (ja) * 2003-12-26 2011-03-09 マナック株式会社 一剤型重炭酸透析用固形剤及びその製造方法
KR20060129363A (ko) 2004-02-09 2006-12-15 니프로 가부시키가이샤 투석용 고형제제 및 그 제조방법
CN1938058A (zh) 2004-03-30 2007-03-28 尼普洛株式会社 透析用固体制剂
US20070231395A1 (en) 2004-03-30 2007-10-04 Toshiya Kai Solid Pharmaceutical Preparation for Dialysis
CA2570110A1 (en) 2004-06-17 2006-01-19 Gopal Iyengar Multi-layer, high barrier packaging materials
US7544301B2 (en) 2004-08-19 2009-06-09 Hhd Llc Citrate-based dialysate chemical formulations
US20090294360A1 (en) 2005-01-07 2009-12-03 Ajinomoto Co., Inc. Dialysis preparation
RU2311202C1 (ru) 2006-02-08 2007-11-27 Общество С Ограниченной Ответственностью "Нпо "Нефрон" Способ получения кислотного компонента для бикарбонатного гемодиализа
US8133194B2 (en) 2006-02-22 2012-03-13 Henry Ford Health System System and method for delivery of regional citrate anticoagulation to extracorporeal blood circuits
JP5592609B2 (ja) 2006-12-12 2014-09-17 エイワイファーマ株式会社 鉄代謝改善剤
TWI419683B (zh) 2007-03-14 2013-12-21 Ajinomoto Kk 骨代謝改善劑
TWI516284B (zh) 2007-05-31 2016-01-11 味之素股份有限公司 透析用固態製劑
WO2010055963A1 (en) 2008-11-17 2010-05-20 Lee, Jin Tae Manufacturing method of acetate-free dialysate composition
WO2010112570A1 (en) * 2009-03-31 2010-10-07 Gambro Lundia Ab Dialysis solution
WO2010112547A1 (en) * 2009-03-31 2010-10-07 Gambro Lundia Ab Dialysis precursor composition
EP2585039B1 (en) * 2010-06-23 2018-04-25 Gambro Lundia AB Dialysis precursor composition
PL2585076T3 (pl) * 2010-06-23 2015-08-31 Gambro Lundia Ab Kompozycja prekursora do dializy
WO2012175353A1 (en) * 2011-06-20 2012-12-27 Gambro Lundia Ab Dialysis precursor composition
WO2012175354A1 (en) * 2011-06-20 2012-12-27 Gambro Lundia Ab Dialysis precursor composition
DE102011106248A1 (de) * 2011-07-01 2013-01-03 Fresenius Medical Care Deutschland Gmbh Behälter, Verwendung, Dialysegerät oder Zubereitungseinheit sowie Verfahren zur Herstellung eines Konzentrats
SE536913C2 (sv) * 2012-03-08 2014-10-28 Gambro Lundia Ab Komposition för dialys

Also Published As

Publication number Publication date
EP4223290A1 (en) 2023-08-09
CN104159579B (zh) 2017-06-30
AU2013201615B2 (en) 2015-02-19
JP6125545B2 (ja) 2017-05-10
EP2822549B1 (en) 2023-05-24
EP4223290B1 (en) 2026-01-21
US20160354311A1 (en) 2016-12-08
JP2015509514A (ja) 2015-03-30
KR20140132006A (ko) 2014-11-14
US9452149B2 (en) 2016-09-27
EP2822549A1 (en) 2015-01-14
US20150024068A1 (en) 2015-01-22
US9724298B2 (en) 2017-08-08
AU2013201615A1 (en) 2013-09-26
CN104159579A (zh) 2014-11-19
CA2865315A1 (en) 2013-09-12
CA2865315C (en) 2020-06-09
SE1250217A1 (sv) 2013-09-09
WO2013131906A1 (en) 2013-09-12
SE536913C2 (sv) 2014-10-28
KR102062932B1 (ko) 2020-01-06

Similar Documents

Publication Publication Date Title
JOP20180102A1 (ar) مركب صيدلاني
JO3343B1 (ar) أحماض 5- أمينوتتراهيدروكوينولين-2- كربوكسيليك جديدة واستخدامها
MX2012015188A (es) Composiciones de liberacion controlada con efecto de alimentos reducido.
MY172578A (en) Oral dosing of glp-1 compounds
PH12015502216A1 (en) Compositions and methods for improving the health of aquatic animals
MX2014010455A (es) Metodos y composiciones para tratar enfermedad de huntington.
NZ628294A (en) Compositions and methods of use of phorbol esters for the treatment of stroke
BR112014032049A2 (pt) citrato férrico e suplemento de ferro oral
MX2021004211A (es) Composiciones vacuna.
AU342358S (en) Dental bite block
IL232777A0 (en) Antibacterial preparations comprising dgla, ohepa-15, and/or hetre-15 and methods of using them
AP2014007399A0 (en) Phenyl-3-AZA-bicycloÄ3.1.0Ühex-3-YL-methanones andthe use thereof as medicament
CR20140594A (es) Composiciones farmacéuticas y tratamiento de mastitis
MX345926B (es) Nuevas composiciones, producción de las mismas y uso de las mismas para la producción de poliamidas coladas.
MX357284B (es) Compuestos de quinona para tratar enfermedades mediadas por ape1.
MX359181B (es) Hidrolizado de colágeno y uso del mismo.
PH12015501099A1 (en) Synbiotic composition and use thereof
IN2014DN11078A (enExample)
IN2014DN06738A (enExample)
IN2014MN01733A (enExample)
IN2014MN01382A (enExample)
UA117567C2 (uk) Композиція, яка стимулює лактацію, на основі фосфатидилсерину
MA40027A (fr) Composition pharmaceutique comprenant un bêta-2 agoniste et un agent anticholinergique
MX2015001648A (es) Composiciones que comprenden derivados de espicamicina y metodos de uso de los mismos.
IN2012DE00826A (enExample)